Funding shortage shuts cancer trials
Up to 95 clinical trials testing experimental anticancer drugs may have to be delayed or closed altogether because of federal funding cuts, according to the Cancer Cooperative Groups.
Archives for February 19, 2007
First SafeBridge certification awarded in Europe
Northern Ireland-based Almac Services has recently been awarded a potent compound safety certification by SafeBridge, confirming that Almac is capable of handling potent compounds safely and is able to limit exposure using closed laboratory systems.
Pharmacopeia tout 2-for-1 cardiovascular drug
Scientists at Pharmacopeia have stitched together the active parts of two molecules to form a single drug, which it claims could treat several cardiovascular diseases more effectively, including kidney disease caused by diabetes.
Ranbaxy raided by US officials
The US offices of Indian pharmaceutical company Ranbaxy were subjected to a search by federal officials the company reported last week.
Key step in formation of malignant growths discovered
The p53 gene has been shown to suppress the movement of malignant growths providing new targets for anticancer therapies.
French law disallows 'generic' biosimilars
The French Parliament has adopted legislation which prevents biosimilar medicinal products from being classed as generics and bans the automatic substitution of one biological medicine for another.
DSM Pharma & Crucell reach milestone in antibody production
The collaboration between DSM Pharmaceutical Products and biotechnology firm Crucell has raised the bar for antibody production, whilst decreasing manufacturing costs.